381 related articles for article (PubMed ID: 33992723)
1. Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy.
Zada S; Hwang JS; Ahmed M; Lai TH; Pham TM; Elashkar O; Kim DR
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188565. PubMed ID: 33992723
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.
Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM
Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310
[TBL] [Abstract][Full Text] [Related]
3. Control of the Epithelial-to-Mesenchymal Transition and Cancer Metastasis by Autophagy-Dependent SNAI1 Degradation.
Zada S; Hwang JS; Ahmed M; Lai TH; Pham TM; Kim DR
Cells; 2019 Feb; 8(2):. PubMed ID: 30736337
[TBL] [Abstract][Full Text] [Related]
4. A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.
Wang Y; Bonavida B
Crit Rev Oncog; 2018; 23(5-6):281-305. PubMed ID: 30311561
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity.
Ashrafizadeh M; Zarrabi A; Orouei S; Kiavash Hushmandi ; Hakimi A; Amirhossein Zabolian ; Daneshi S; Samarghandian S; Baradaran B; Najafi M
Eur J Pharmacol; 2021 Feb; 892():173660. PubMed ID: 33310181
[TBL] [Abstract][Full Text] [Related]
6. EMT, cancer stem cells and autophagy; The three main axes of metastasis.
Babaei G; Aziz SG; Jaghi NZZ
Biomed Pharmacother; 2021 Jan; 133():110909. PubMed ID: 33227701
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
[TBL] [Abstract][Full Text] [Related]
8. Autophagy-mediated degradation of NOTCH1 intracellular domain controls the epithelial to mesenchymal transition and cancer metastasis.
Zada S; Hwang JS; Lai TH; Pham TM; Ahmed M; Elashkar O; Kim W; Kim DR
Cell Biosci; 2022 Feb; 12(1):17. PubMed ID: 35164848
[TBL] [Abstract][Full Text] [Related]
9. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
10. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
11. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic roles of EMT-inducing transcription factors.
Puisieux A; Brabletz T; Caramel J
Nat Cell Biol; 2014 Jun; 16(6):488-94. PubMed ID: 24875735
[TBL] [Abstract][Full Text] [Related]
14. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.
Yang SW; Ping YF; Jiang YX; Luo X; Zhang X; Bian XW; Yu PW
Oncotarget; 2016 Jun; 7(26):39279-39292. PubMed ID: 27276686
[TBL] [Abstract][Full Text] [Related]
15. Targeting autophagy using natural compounds for cancer prevention and therapy.
Deng S; Shanmugam MK; Kumar AP; Yap CT; Sethi G; Bishayee A
Cancer; 2019 Apr; 125(8):1228-1246. PubMed ID: 30748003
[TBL] [Abstract][Full Text] [Related]
16. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
[TBL] [Abstract][Full Text] [Related]
17. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
18. Targeting autophagy in cancer stem cells as an anticancer therapy.
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
[TBL] [Abstract][Full Text] [Related]
19. Programmed Cell Death, from a Cancer Perspective: An Overview.
Mishra AP; Salehi B; Sharifi-Rad M; Pezzani R; Kobarfard F; Sharifi-Rad J; Nigam M
Mol Diagn Ther; 2018 Jun; 22(3):281-295. PubMed ID: 29560608
[TBL] [Abstract][Full Text] [Related]
20. Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer.
Gugnoni M; Sancisi V; Manzotti G; Gandolfi G; Ciarrocchi A
Cell Death Dis; 2016 Dec; 7(12):e2520. PubMed ID: 27929542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
